A Dose Escalation Phase 1 Study Evaluating the Safety and Pharmacokinetics of an Inhaled COVID-19 Inhibitor Delcetravir in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study will be a single center, Phase I, randomized, double-blind, placebo controlled, single and multiple ascending dose (SAD/MAD) study evaluating the safety, tolerability, and PK of Delcetravir after administration via oral inhalation in healthy subjects.
Epistemonikos ID: a000b00549012186017fa053eabf76b9cbdd78ae
First added on: Jul 13, 2022